Podimetrics, Inc.

Podimetrics, Inc. develops remote monitoring solutions for diabetic foot health and complex diabetes care management. The company manufactures the SmartMat™ (and next-generation SmartMat+), an FDA-cleared wearable platform that detects early signs of foot inflammation and diabetic foot ulcers through daily 20-second contact monitoring. The SmartMat collects thermal and pressure data to identify high-risk individuals before complications emerge. The solution integrates remote monitoring technology with personalized clinical support and timely alerts to enable early intervention. Podimetrics targets payors, healthcare systems, and employers managing high-risk diabetic populations. Clinical evidence supports reductions in amputations, hospitalizations, and diabetes-related complications. The company emphasizes that 85% of diabetic foot ulcers are preventable, and one-third of diabetes spending addresses lower-extremity complications. The platform combines hardware, cloud-based analytics, and clinical outreach services to support complex diabetes care workflows and improve outcomes while reducing utilization costs.